Overview
NEAUTUS (02206)
Sichuan Neautus Traditional Chinese Medicine Co., Ltd. engages in the research and development, production, and sale of traditional Chinese medicine decoction-r...
- Open
- 73.700
- High
- 75.700
- Low
- 70.000
- Prev. Close
- 73.700
- Volume
- 282.45K
- Turnover
- 20.52M
- Avg Price
- 72.657
- Bid/Ask Ratio
- 63.64%
- Amplitude
- 7.73%
- 52wk High
- 94.100
- Volume Ratio
- 0.00
- Turnover Ratio
- 0.43%
- 52wk Low
- 51.250
- HK Mkt Cap
- 4.73B
- Market CapHKD
- 4.73B
- P/ETTM
- 34.60
- P/EDynamic
- 40.72
- P/EStatic
- --
- EPSTTM
- 2.10
- EPSDynamic
- 1.78
- EPSStatic
- --
- BVPS
- 10.42
- P/B
- 6.96
- HK Shares
- 65.17M
- Dividend YieldTTM
- --
- DividendTTM
- --
- Shares
- 65.17M
- Min lot size
- 50
- Currency
- HKD
Daily Events
- Nov, 13
Neautus (2206.HK) spiked then reversed, closing at HK$73.7 for a 15.3% decline from the prior close of HK$87.0 after touching HK$87.8 at the open and sliding to HK$68.8 by 10:16 in the morning session, a swing of more than 20%; that gave back much of the 71.6% debut gain to HK$69. The 2,192x oversubscription of its HK$329 million offering left a crowded short-term holder base in a thin float, and an MACD golden cross paired with fading volume points the same way, with turnover of just 397,320 shares worth HK$29.3 million and a 0.61% turnover rate. At HK$73.7 the stock sits 21.7% below the 52-week high of HK$94.1 set on listing day yet 43.8% above the HK$51.25 low, under both the MA20 and MA60 at HK$76.92, trimming its year-to-date gain to 6.8%. A 35.2x PE and 7.08x PB on HK$4.80 billion of market value frame that positioning, though no quarterly earnings figures are available yet to anchor it.
News
Weekly Review · Weekly Recap | NEAUTUS this week, first leg of price discovery
Market Movers · 新荷花(2206.HK)跌约 12%。
AASTOCKS News · NEAUTUS Closes Up 71.6% to $69
Weekly Review · Weekly Recap | 2206.HK this week, public offer oversubscribed 2,192 times
IPO Tracker · IPO Tracker | Neautus's HK$329 million offering: the numbers behind China's second-largest TCM decoction pieces supplier
SCMP · Has Hong Kong’s IPO boom hit a wall – or is a year-end rush still to come?
